Business Context and Reporting Period
This Form 8-K is filed by Tharimmune, Inc. (not Canton Strategic Holdings, Inc.) on September 5, 2025. The filing addresses a regulatory matter regarding the company's continued listing on The Nasdaq Stock Market LLC under the trading symbol THAR.
Key Financial Metrics
- Stockholders' Equity: $6,876,335 as of August 31, 2025.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these metrics.
Material Changes
The primary event reported is the resolution of a compliance issue with Nasdaq. The company previously faced a potential delisting risk but has now demonstrated compliance with Listing Rule 5550(b)(1) based on its stockholders' equity position.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms that Nasdaq has determined the company complies with the minimum stockholders' equity requirement and that the matter is now closed. No forward-looking guidance, risk factors, or unusual items are disclosed in this specific report.
Investor Verification Checklist
- Verify the company name is Tharimmune, Inc. (discrepancy noted in request metadata).
- Confirm the stockholders' equity of $6,876,335 as of August 31, 2025, in the most recent Form 10-Q or 10-K.
- Monitor future filings for any new compliance notices from Nasdaq.